Elevation Oncology Stock Probability of Future Stock Price Finishing Over 0.6

ELEV Stock  USD 0.58  0.05  7.94%   
Elevation Oncology's future price is the expected price of Elevation Oncology instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Elevation Oncology performance during a given time horizon utilizing its historical volatility. Check out Elevation Oncology Backtesting, Elevation Oncology Valuation, Elevation Oncology Correlation, Elevation Oncology Hype Analysis, Elevation Oncology Volatility, Elevation Oncology History as well as Elevation Oncology Performance.
For more information on how to buy Elevation Stock please use our How to Invest in Elevation Oncology guide.
  
At this time, Elevation Oncology's Price Book Value Ratio is fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to climb to 0.01 in 2024, whereas Price To Operating Cash Flows Ratio is likely to drop (0.34) in 2024. Please specify Elevation Oncology's target price for which you would like Elevation Oncology odds to be computed.

Elevation Oncology Target Price Odds to finish over 0.6

The tendency of Elevation Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 0.60  or more in 90 days
 0.58 90 days 0.60 
about 42.14
Based on a normal probability distribution, the odds of Elevation Oncology to move over $ 0.60  or more in 90 days from now is about 42.14 (This Elevation Oncology probability density function shows the probability of Elevation Stock to fall within a particular range of prices over 90 days) . Probability of Elevation Oncology price to stay between its current price of $ 0.58  and $ 0.60  at the end of the 90-day period is about 15.73 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.38 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Elevation Oncology will likely underperform. Additionally Elevation Oncology has an alpha of 0.0379, implying that it can generate a 0.0379 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Elevation Oncology Price Density   
       Price  

Predictive Modules for Elevation Oncology

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Elevation Oncology. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Elevation Oncology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.030.585.77
Details
Intrinsic
Valuation
LowRealHigh
0.081.626.81
Details
Naive
Forecast
LowNextHigh
0.010.545.72
Details
7 Analysts
Consensus
LowTargetHigh
4.404.835.36
Details

Elevation Oncology Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Elevation Oncology is not an exception. The market had few large corrections towards the Elevation Oncology's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Elevation Oncology, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Elevation Oncology within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.04
β
Beta against Dow Jones1.38
σ
Overall volatility
0.05
Ir
Information ratio 0.01

Elevation Oncology Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Elevation Oncology for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Elevation Oncology can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Elevation Oncology had very high historical volatility over the last 90 days
Elevation Oncology has some characteristics of a very speculative penny stock
Elevation Oncology has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (45.7 M) with profit before overhead, payroll, taxes, and interest of 0.
Elevation Oncology currently holds about 122.54 M in cash with (56.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.26, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Elevation Oncology has a frail financial position based on the latest SEC disclosures
Over 84.0% of the company shares are held by institutions such as insurance companies
Latest headline from thelincolnianonline.com: Elevation Oncology Given Market Outperform Rating at JMP Securities

Elevation Oncology Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Elevation Stock often depends not only on the future outlook of the current and potential Elevation Oncology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Elevation Oncology's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding34.1 M
Cash And Short Term Investments83.1 M

Elevation Oncology Technical Analysis

Elevation Oncology's future price can be derived by breaking down and analyzing its technical indicators over time. Elevation Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Elevation Oncology. In general, you should focus on analyzing Elevation Stock price patterns and their correlations with different microeconomic environments and drivers.

Elevation Oncology Predictive Forecast Models

Elevation Oncology's time-series forecasting models is one of many Elevation Oncology's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Elevation Oncology's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Elevation Oncology

Checking the ongoing alerts about Elevation Oncology for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Elevation Oncology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Elevation Oncology had very high historical volatility over the last 90 days
Elevation Oncology has some characteristics of a very speculative penny stock
Elevation Oncology has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (45.7 M) with profit before overhead, payroll, taxes, and interest of 0.
Elevation Oncology currently holds about 122.54 M in cash with (56.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.26, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Elevation Oncology has a frail financial position based on the latest SEC disclosures
Over 84.0% of the company shares are held by institutions such as insurance companies
Latest headline from thelincolnianonline.com: Elevation Oncology Given Market Outperform Rating at JMP Securities

Additional Tools for Elevation Stock Analysis

When running Elevation Oncology's price analysis, check to measure Elevation Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevation Oncology is operating at the current time. Most of Elevation Oncology's value examination focuses on studying past and present price action to predict the probability of Elevation Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevation Oncology's price. Additionally, you may evaluate how the addition of Elevation Oncology to your portfolios can decrease your overall portfolio volatility.